Ahmed H A Hassanein

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Combination Therapy

Coronavirus Disease

Top Venues

Pharmacy practice

This page only lists publications with an associated author ORCID identifier.

Publications

Amira S A Said, Raghda R S Hussein, Doaa Mahmoud Khalil, Alzhraa M Fahmy, Ahmed H A Hassanein, Lamiaa N Abdelaty
Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial. Pharmacy practice 21 (1) (2022)
Amira S A Said, Raghda R S Hussein, Doaa Mahmoud Khalil, Alzhraa M Fahmy, Ahmed H A Hassanein, Lamiaa N Abdelaty
Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial. Pharmacy practice 21 (1) (2022)
Amira S A Said, Raghda R S Hussein, Doaa Mahmoud Khalil, Alzhraa M Fahmy, Ahmed H A Hassanein, Lamiaa N Abdelaty
Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial. Pharmacy practice 21 (1) (2022)
Amira S A Said, Raghda R S Hussein, Doaa Mahmoud Khalil, Alzhraa M Fahmy, Ahmed H A Hassanein, Lamiaa N Abdelaty
Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial. Pharmacy practice 21 (1) (2022)